Skip to main content

Table 2 Clinical pain intensity scores (minimum, average, and maximum) over the last week measured using a numerical rating scale (NRS) (0–10, “0” indicating no pain and “10” indicating worst imaginable pain) from patients with PFIP and number of attacks pre- and post-pharmacological treatment

From: Amitriptyline–perphenazine therapy for persistent idiopathic facial pain: translational perspectives from a retrospective study

 

Pre-treatment

95% CI

Post-treatment

95% CI

p -value

NRS min

2.61 ± 0.91

2.2–2.9

1.55 ± 0.85

1.2–1.8

 < 0.00001

NRS ave

5 ± 0.93

4.6–5.3

4.16 ± 0.93

3.8–4.5

 < 0.00001

NRS max

8.51 ± 0.89

8–9

6.09 ± 1.60

5.5–6.6

 < 0.00001

No. of attacks

5 ± 1.57

4–6

4 ± 0.99

3–4

0.00026

  1. Data are presented as mean ± SD and CI (95%). The number of attacks is presented as MED ± SD